ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Boston-based Allonnia has raised a $20 million addition to its series A round from the cleantech investment fund Evok Innovations to speed development of microbial technology that degrades stubborn pollutants like per- and polyfluoroalkyl substances (PFAS) in water. Allonnia spun off from Ginkgo Bioworks in October with $40 million from Battelle Memorial Institute, General Atlantic, and other backers. The start-up will acquire an Evok-owned company, Metabolik Technologies, which develops microbes to remediate pollutants such as naphthenic acid from oil and gas extraction in the Alberta oil sands.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X